This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

Awards spotlight — JB McCormick, MD Award
NSH
Sponsored by James and Suzanne McCormick Family Trust

This award is generously sponsored by Dr. McCormick and his family. The award consists of a functioning exact replica of an 1800 Liberkuhn Compass Microscope and an eight book boxed set of The Science Heritage Library, concerning the history of the microscope and Histotechnology.

Award criteria:
This award is presented for outstanding and exceptional service to the National Society for Histotechnology. The McCormick Family Trust has been sponsoring this award since 1978, that's pretty amazing. Thanks Dr. McCormick! Some of the past recipients are Freida Carson in 1983, Sheron Lear in 2001, Jan Minshew in 2008, Skip Brown in 2011 and Peggy Wenk in 2013. You can see a full list of the recipients on the NSH website. If you know of anyone who has supported the NSH through the years and support can consist of many things, from lecturing at state and local meetings, to serving on a committee or as an elected official. These individuals are highly dedicated to their profession. If you know of someone that is deserving of this prestigious award then nominate them.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




TOP STORIES


Drug companies pin hopes on trial reach to enroll patients in clinical trials faster
Forbes
Two years ago, Pfizer, Novartis and Eli Lilly set aside competition to form a consortium called Patients to Trials. Goal: To solve an issue that has bedeviled their industry and slowed drug development — namely how to enroll patients in clinical trials faster. According to CenterWatch, 75 percent of the public is unaware of clinical studies, and nearly half of trials don't fulfill their recruitment goals, causing delays.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Mayo Clinic pilots use of telemedicine kiosks for its employees, but will pathologists be included to provide medical consultations?
Dark Daily
Coming soon to a pharmacy, school, retail store or employer near you is a new generation of walk-in telemedicine kiosks. These kiosks are specifically designed to allow consumers to have private medical consultations with physicians. For that reason, pathologists and their medical specialty associations may find it timely to engage the company offering these kiosks with the goal of incorporating pathology consultations in the service mix offered by this new generation of telemedicine kiosks.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  GBI Cost Effective Products

GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species. We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.
 


Apple's ResearchKit — the real impact on clinical trials
Bioscience Technology
Apple recently released news about its new ResearchKit, a medical platform that intends to turn the iPhone and HealthKit into diagnostic tools. The technology, which enables researchers to create apps that gather new types of health data from users who opt-in, has gotten quite a bit of attention throughout the healthcare and technology communities.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Miss an issue of Under The Microscope? Click here to visit the Under The Microscope archive page.


Exco InTouch predicts substantial growth in device integration across clinical trials and healthcare programs
Clinical Leader
Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, predicts a substantial increase in device integration in clinical trials and real world programs in 2015 and beyond.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Small group of labs, test manufacturers float alternative to FDA laboratory-developed tests guidance
GenomeWeb
Is it possible to craft a framework for regulating diagnostics that pleases everyone? A small group of labs and test manufacturers has taken a shot at it by coming up with its own proposal for regulating so-called in vitro clinical tests that it hopes will be an acceptable compromise for industry players that often disagree on the regulation of laboratory-developed tests.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  PRODUCT SHOWCASES
AutoSection® - Microtome with a Brian

Conserve tissue and provides reproducible sections for advanced staining

  • Automatically aligns blocks to the blade in seconds
  • Reduces QC rejected slides through precision sectioning
  • Saves wrists and shoulders from unnecessary pain caused by repetitive motion
  • Click here to see all AutoSection has to offer

    For more information call Sakura 800-725-8723
  • Hassle Free Block Storage Cabinet


    Avantik Biogroup is proud to introduce another Customer Requested Quality Innovation for Histology...the Avantik Biogroup Block Storage Cabinet! We introduced Hassle-Free Drawer Technology with Interlocking Stackability and More Clearance between the top of the blocks and the drawers to achieve the industry's first Jam-Free, Hassle-Free Block Storage Cabinet!



    To find out how to feature your company in Under the Microscope and other advertising opportunities, Contact Geoffrey Forneret at 469.420.2629

    More info


    IN THE NEWS


    Gladstone researchers identify way to prevent multiple sclerosis development in mice
    News-Medical.Net
    Scientists from the Gladstone Institutes have discovered a way to prevent the development of multiple sclerosis in mice. Using a drug that blocks the production of a certain type of immune cell linked to inflammation and autoimmunity, the researchers successfully protected against the onset of MS in an animal model of the disease. The scientists say the next step is to test this strategy using other autoimmune disorders.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Tumor genomics: Sequence normal tissue, too
    MedPage Today
    The standard approach of analyzing malignant tumors for unique genetic mutations to target therapy may not be sufficient and may, in fact, lead to inappropriate treatment, researchers said. For accuracy, tumor genomes should also be compared with matched samples of DNA from patient's noncancerous tissue, concluded investigators led by Sian Jones, Ph.D., of Personal Genome Diagnostics, in Baltimore, who reported their findings online in Science Translational Medicine.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE




    Hepatitis C linked to increased risk of liver cancer, other cancers
    Medical News Today
    Researchers have long known that patients with hepatitis C are at increased risk of liver cancer. But a new study recently presented at the European Association for the Study of the Liver's 50th International Liver Congress in Vienna, Austria, finds hepatitis C may also raise the risk of developing other cancers.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Researchers discover key mechanism in neural death that causes Parkinson's disease
    News-Medical.Net
    In studying the molecular biology of brain development, a team of researchers led by Ludwig Stockholm director Thomas Perlmann has discovered how disruption of a developmental mechanism alters the very nerve cells that are most affected in Parkinson's disease. They have also explained how such disruption induces a lethal dysfunction in the internal, house-keeping processes of such neurons. The results of their study, which took nearly four years to complete and involved the exquisitely targeted manipulation of mouse genes to generate a unique model of the disease, are published in the current issue of the journal Nature Neuroscience.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    TRENDING ARTICLES
    Missed last week's issue? See which articles your colleagues read most.

        Are CLIA inspections of clinical pathology labs getting tougher? Why it pays to achieve 'inspection readiness' (Dark Daily)
    How wearables and mobile health tech are reshaping clinical trials (VentureBeat)
    Team shows how blood-brain barrier is maintained (University of Pennsylvania via Medical Xpress)
    CAP and NSH release new guideline to improve patient safety (NSH)

    Don't be left behind. Click here to see what else you missed.
     

    Under the Microscope
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Ashley Whipple, Senior Content Editor, 469.420.2642   
    Contribute news

    This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
    Recent issues
    April 28, 2015 blast
    April 23, 2015 Blast
    April 22, 2015
    April 15, 2015



    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063